Intelligent Wound Healing System with Integrated AI, IoT, Blockchain, and New Materials

Publication ID: 24-11857631_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Wound Healing System with Integrated AI, IoT, Blockchain, and New Materials,” Published Technical Disclosure No. 24-11857631_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857631_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,631.

Summary of the Inventive Concept

A novel wound healing system integrating a hydrogel-based therapeutic protein delivery system with AI, IoT, blockchain, and new materials to provide personalized, real-time monitoring, and optimized treatment outcomes.

Background and Problem Solved

The original patent disclosed a composition for delivering multiple therapeutic proteins for wound healing. However, the patent had limitations in terms of monitoring wound healing progress, adjusting treatment protocols, and securely storing patient data. The new inventive concept addresses these limitations by integrating the original composition with AI, IoT, blockchain, and new materials to provide a more comprehensive and effective wound healing system.

Detailed Description of the Inventive Concept

The new system comprises a hydrogel with a complex or coacervate of a polycationic polymer, a polyanionic polymer, fibroblast growth factor 2 (FGF-2), and stromal cell-derived factor 1 alpha (SDF-1α). The system integrates with an AI-powered monitoring device to track wound healing progress and adjust treatment protocols accordingly. Additionally, the system utilizes blockchain technology to securely store and share patient treatment data. The system also integrates with an IoT network to remotely monitor and adjust treatment protocols in real-time. Furthermore, the system utilizes machine learning algorithms to predict optimal treatment protocols based on patient data and integrates with new materials for customized wound dressings.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and new materials with the original composition, providing a novel and non-obvious solution for wound healing. The inventive step lies in the synergistic combination of these distinct technologies to create a more comprehensive and effective wound healing system.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the system with other technologies such as robotics, 3D printing, or nanotechnology. Variations of the system could include using different types of polymers, growth factors, or new materials to customize the system for specific wound types or patient needs.

Potential Commercial Applications and Market

The intelligent wound healing system has significant commercial potential in the wound care industry, with applications in hospitals, clinics, and home healthcare settings. The system could be marketed to healthcare providers, medical device companies, and pharmaceutical companies, with potential revenue streams from device sales, data analytics services, and licensing agreements.

CPC Classifications

SectionClassGroup
A A61 A61K47/36
A A61 A61K9/0019
A A61 A61K9/06
A A61 A61K35/16
A A61 A61K35/19
A A61 A61K38/177
A A61 A61K38/18
A A61 A61K38/1825
A A61 A61K38/195
A A61 A61K47/34
A A61 A61K47/42
A A61 A61L15/225
A A61 A61L15/40
A A61 A61L15/44
A A61 A61L27/18
A A61 A61L27/20
A A61 A61L27/225
A A61 A61L27/26
A A61 A61L27/3616
A A61 A61L27/52
A A61 A61L27/54
A A61 A61L27/56
A A61 A61L31/041
A A61 A61L31/042
A A61 A61L31/046
A A61 A61L31/145
A A61 A61L31/16
A A61 A61P9/10
A A61 A61L2300/25
A A61 A61L2300/252
A A61 A61L2300/414
A A61 A61L2300/418
A A61 A61L2400/04
A A61 A61L2430/20

Original Patent Information

Patent NumberUS 11,857,631
TitleProtection and delivery of multiple therapeutic proteins
Assignee(s)UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION